Mild cases of TTP can allow for first-line therapies such as glucocorticoids and plasma exchange therapy to stabilize the patient until the ADAMTS-13 test comes back, and further treatment can follow [3,4]. Here, ADAMTS13 is linked to thrombotic thrombocytopenic purpura.